Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07195721 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of PROSE or Scleral Lenses on Mental Health

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 44 words
    • Site contact updated
    • Study title expanded, about 2 words
    v3
  2. Primary endpoint revised
    • Secondary endpoints revised (2)
    • Site contact updated
    • Study description expanded, about 1 word
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Boston Sight
2 trials monitored
See 1 trial at risk
Depression
3,055 trials monitored
See 173 trials at risk
The goal of this prospective clinical trial is to evaluate the effect that prosthetic replacement of the ocular surface ecosystem (PROSE, BostonSight, Needham MA) treatment may have on mental health, particularly affective mood disorders. Correlation between changes in mental health and ocular symptom improvement and/or visual function improvement will be evaluated.
Trial Details
NCT Number NCT07195721
Lead Sponsor Boston Sight
Conditions
(from sponsor)		 Depression - Major Depressive Disorder
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov